D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

A subretinal gene therapy was well tolerated 1 year after treatment, with no drug-related serious adverse events, in a small ...

In an early phase trial, gene therapy showed an ability to restore function to rods and cones as well as functional vision ...

D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...